These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16880137)

  • 1. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values.
    Marlar RA; Potts RM; Marlar AA
    Am J Clin Pathol; 2006 Sep; 126(3):400-5. PubMed ID: 16880137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
    Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
    Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of specimen hemolysis on coagulation test results.
    Laga AC; Cheves TA; Sweeney JD
    Am J Clin Pathol; 2006 Nov; 126(5):748-55. PubMed ID: 17050072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of citrate concentration in specimen collection tubes on the International Normalized Ratio.
    Danielson CF; Davis K; Jones G; Benson J; Arney K; Martin J
    Arch Pathol Lab Med; 1997 Sep; 121(9):956-9. PubMed ID: 9302927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drawing a discard tube on PT and APTT results in healthy adults.
    Bamberg R; Cottle JN; Williams JC
    Clin Lab Sci; 2003; 16(1):16-9. PubMed ID: 12587654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of temperature and time before centrifugation of specimens for routine coagulation testing.
    Salvagno GL; Lippi G; Montagnana M; Franchini M; Poli G; Guidi GC
    Int J Lab Hematol; 2009 Aug; 31(4):462-7. PubMed ID: 18371059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect (or lack of it) of severe anemia on PT and APTT results.
    Siegel JE; Swami VK; Glenn P; Peterson P
    Am J Clin Pathol; 1998 Jul; 110(1):106-10. PubMed ID: 9661929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of coagulation parameters in the early period after kidney transplantation.
    Pawlicki J; Cierpka L; Król R; Ziaja J
    Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
    Mineo HK; Garabed RB
    Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of freezing method and storage at -20 degrees C and -70 degrees C on prothrombin time, aPTT and plasma fibrinogen levels.
    Alesci S; Borggrefe M; Dempfle CE
    Thromb Res; 2009 May; 124(1):121-6. PubMed ID: 19128820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT).
    Peterson P; Gottfried EL
    Thromb Haemost; 1982 Apr; 47(2):101-3. PubMed ID: 7101228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine coagulation testing in Vacutainer® Citrate Plus tubes filled at minimum or optimal volume.
    Balboni F; Barbui S; Gallo M; Berardi M; Vezzosi M; Lippi G
    Diagnosis (Berl); 2020 Jan; 7(1):55-60. PubMed ID: 31421038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of coagulation by removing clotting factors part 1: in vitro feasibility study.
    Parker JT; Beutler DS; Sukavaneshvar S; Jacobs N; Solen KA; Mohammad SF
    ASAIO J; 2007; 53(4):415-20. PubMed ID: 17667224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do elevated hematocrits prolong the PT/aPTT?
    Austin M; Ferrell C; Reyes M
    Clin Lab Sci; 2013; 26(2):89-94. PubMed ID: 23772474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of citrate concentration on coagulation test results in dogs.
    Stokol T; Brooks MB; Erb HN
    J Am Vet Med Assoc; 2000 Dec; 217(11):1672-7. PubMed ID: 11110458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemorheologic and blood coagulation studies in 94 patients with chronic obstructive peripheral arterial disease].
    Bracale G; Selvetella L; Bernardo B; Scalise E; Bertone L; De Caterina M
    Ric Clin Lab; 1985; 15 Suppl 1():195-203. PubMed ID: 3929368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions.
    Rizzo F; Papasouliotis K; Crawford E; Dodkin S; Cue S
    Res Vet Sci; 2008 Aug; 85(1):166-70. PubMed ID: 17998140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
    Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
    Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.